This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
SEC.gov
EDGAR
Latest Filings
Filings search tools
Filing Detail
SEC Home
»
Company Search
»
Current Page
Form CORRESP
- Correspondence:
SEC
Accession
No.
0000950144-07-006507
Filing Date
2007-07-11
Accepted
2007-07-11 17:02:44
Documents
8
Document Format Files
Seq
Description
Document
Type
Size
1
filename1.htm
CORRESP
66419
2
GRAPHIC
g06286c2g0628623.gif
GRAPHIC
182666
3
GRAPHIC
g06286c2g0628624.gif
GRAPHIC
195584
4
GRAPHIC
g06286c2g0628625.gif
GRAPHIC
193468
5
GRAPHIC
g06286c2g0628626.gif
GRAPHIC
216259
6
GRAPHIC
g06286c2g0628627.gif
GRAPHIC
204283
7
GRAPHIC
g06286c2g0628628.gif
GRAPHIC
211069
8
GRAPHIC
g06286c2g0628629.gif
GRAPHIC
62599
Complete submission text file
0000950144-07-006507.txt
1812955
Mailing Address
2525 WEST END AVENUE
SUITE 950
NASHVILLE
TN
37203
Business Address
2525 WEST END AVENUE
SUITE 950
NASHVILLE,
TN
37203
615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer)
CIK
:
0001087294 (see all company filings)
EIN.
:
000000000
Type:
CORRESP
SIC
:
2834
Pharmaceutical Preparations